Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-Release vs. Sublingual Buprenorphine for OUD with Fentanyl Use
NCT04352166Phase 2Completed
- Start
- Dec 2020
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine extended-release injection in opioid use disorder (OUD). Started Dec 2020; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04352166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04352166.